Covishield

The Indian drugmaker said it is committed to transparency and safety and had taken all the required steps to disclose the rare side effects of the vaccine

Shreyas Talpade says his heart attack could be the side effect of Covid vaccine, 'I would not negate the theory'

Bollywood actor Shreyas Talpade says he believes that a reason for his ill health and massive heart attack in December, last year, could be a side effect of the 'Covishield Vaccine', now that the news of the vaccine causing blood clots has left many surprised.

AstraZeneca Pharma fall 3% despite healthy Q2 net profit, revenue growth

The stock slipped amid reports of the Oxford-AstraZeneca COVID-19 vaccine, known as Vaxzevria in Europe and licensed as Covishield in India, facing a legal challenge the UK

Serum Institute of India restarts manufacturing of COVID-19 vaccine Covishield

He said the company already has six million booster doses of Covovax vaccine available and adults must take the booster shot.

Covishield immune responses against Covid variants higher than Covaxin: Study

Vaccination following exposure to the Delta or Omicron variants of SARS-CoV-2 is likely to affect the quality, quantity and duration of immune responses.

Serum Institute to start free COVID vaccine supply to government, other manufacturers await order

The government has sent a consignment list for supplying 80 lakh doses of Covishield to different consignees to Serum Institute of India, which will start the supply soon, an official said.

Serum Institute to provide 2 crore Covishield doses to central govt free of cost

According to an official source, Prakash Kumar Singh, Director of Government and Regulatory Affairs at the Serum Institute, has written to the Health Ministry offering the doses worth Rs 410 crore free of cost.

Bill Gates, Serum Institute get Bombay HC notice after man claims Covishield side-effects killed daughter

Petitioner Dilip Lunwat, the petitioner, said his daughter, a medical student, had severe headaches and vomiting after taking the vaccine in 2021. She was taken to a hospital where doctors found bleeding in her brain.

HC seeks response from SII, others on plea demanding Rs 1,000 crore compensation for woman's death

Petitioner Dilip Lunwat has also made Microsoft founder Bill Gates whose foundation had partnered with the SII, the Union government, Maharashtra government and Drug Controller of India respondents to the plea.

Government nod to Corbevax as precaution dose for adults vaccinated with Covaxin, Covishield

This is for the first time that a booster dose that is different from the one used for primary vaccination against Covid has been allowed in the country.

Corbevax approved as precaution dose for adults vaccinated with Covaxin, Covishield

This is for the first time that a booster dose that is different from the one used for primary vaccination against Covid has been allowed in the country.

COVID-19 shots administered in India about to overtake count in all of Europe, North America

This is a remarkable feat, considering that all the vaccine doses administered in the country are made locally

Top virologists weigh in for Corbevax booster after primary vaccination with Covishield, Covaxin 

The pharma regulator has approved the first mix-and-match of COVID-19 vaccines in India, but the final say-so lies with the government 

World's biggest vaccine maker Serum halts production with 200 million doses spare

The Serum Institute has produced more than one billion doses of Covishield -- its version of the AstraZeneca jab -- and is a major supplier to the Covax global inoculation programme for poorer countries.

India's 'warm' vaccine candidate effective against Delta, Omicron variants in mice: Study

The heat-tolerant COVID-19 vaccine candidate can be stored at 37 degrees Celsius for four weeks and at 100 degrees Celsius for up to 90 minutes.

Reduce time gap for COVID vaccine booster dose to six months: Serum Institute to govt

New Delhi, Apr 12 Vaccine major Serum Institute of India (SII) has appealed to the government to reduce the gap between the second and booster dose..

SII to give free Covishield vials to private vaccination centres to compensate for price difference

The inventories at the private CVCs would be verified by SII representatives and the claim would then be processed on the basis of their approval.

Moneycontrol Daily: Your Essential 7

A daily round-up of the most interesting articles to help jump-start the day.

Covaxin, Covishield prices slashed to Rs 225 per shot, a day before precaution drive starts

While prices for the Covishield doses were brought down from Rs 600 a shot, Covaxin was slashed from Rs 1,200.

For future orders, SII to provide free replacement if vaccine expires: Adar Poonawalla

"In 10-14 days, Covovax can be available on CoWin at about Rs 900 plus tax," the SII chief executive said.

Huge response to COVID-19 shots for 12-14 age group; private hospitals keep away

Private healthcare providers struggling to use up their stocks of Covishield and Covaxin shots are showing no enthusiasm for the Corbevax vaccination of children.

Explainer: Intranasal vaccine against COVID-19 and why it is awaited so eagerly

As the efficacy trials of the intranasal COVID-19 vaccine from Bharat Biotech begin this week, there are hopes that if successful, such a vaccine may finally bring the pandemic to an end

Adar Poonawalla, CEO of vaccine maker Serum Institute, has a message for Novak Djokovic

Unvaccinated tennis player Novak Djokovic has said that though he is not against COVID-19 vaccines, he will skip tournaments if compelled to take the jab.

Piles of unused COVID-19 jabs near expiry, private hospitals turn to government for bailout

As most vaccine beneficiaries prefer to line up at government hospitals, private hospitals now want the government to buy the doses. Of the nearly 175 crore vaccine doses administered, less than 5 percent have been in private hospitals

Centre spent Rs 28,436 crore on vaccination this fiscal, leaving 27% of the allocated fund unspent

A sum of Rs 35,000 crore was originally proposed to be spent on COVID vaccination as part of 2021-22 budget which was later revised to Rs 39,000 crore. Response to an RTI query has revealed that the government has spent majority of the amount